74 related articles for article (PubMed ID: 21135463)
1. Selective internalization of self-assembled artificial oil bodies by HER2/neu-positive cells.
Chiang CJ; Lin LJ; Lin CC; Chang CH; Chao YP
Nanotechnology; 2011 Jan; 22(1):015102. PubMed ID: 21135463
[TBL] [Abstract][Full Text] [Related]
2. Selective delivery of cargo entities to tumor cells by nanoscale artificial oil bodies.
Chiang CJ; Chen CJ; Lin LJ; Chang CH; Chao YP
J Agric Food Chem; 2010 Nov; 58(22):11695-702. PubMed ID: 20964433
[TBL] [Abstract][Full Text] [Related]
3. Caleosin-assembled oil bodies as a potential delivery nanocarrier.
Chiang CJ; Lin SC; Lin LJ; Chen CJ; Chao YP
Appl Microbiol Biotechnol; 2012 Mar; 93(5):1905-15. PubMed ID: 22127752
[TBL] [Abstract][Full Text] [Related]
4. Functionalized nanoscale oil bodies for targeted delivery of a hydrophobic drug.
Chiang CJ; Lin CC; Lu TL; Wang HF
Nanotechnology; 2011 Oct; 22(41):415102. PubMed ID: 21914943
[TBL] [Abstract][Full Text] [Related]
5. Constitution of stable artificial oil bodies with triacylglycerol, phospholipid, and caleosin.
Chen MC; Chyan CL; Lee TT; Huang SH; Tzen JT
J Agric Food Chem; 2004 Jun; 52(12):3982-7. PubMed ID: 15186126
[TBL] [Abstract][Full Text] [Related]
6. Stability of artificial oil bodies constituted with recombinant caleosins.
Liu TH; Chyan CL; Li FY; Tzen JT
J Agric Food Chem; 2009 Mar; 57(6):2308-13. PubMed ID: 19216529
[TBL] [Abstract][Full Text] [Related]
7. A system for purification of recombinant proteins in Escherichia coli via artificial oil bodies constituted with their oleosin-fused polypeptides.
Peng CC; Chen JC; Shyu DJ; Chen MJ; Tzen JT
J Biotechnol; 2004 Jul; 111(1):51-7. PubMed ID: 15196769
[TBL] [Abstract][Full Text] [Related]
8. Engineering of Escherichia coli for targeted delivery of transgenes to HER2/neu-positive tumor cells.
Chang CH; Cheng WJ; Chen SY; Kao MC; Chiang CJ; Chao YP
Biotechnol Bioeng; 2011 Jul; 108(7):1662-72. PubMed ID: 21337329
[TBL] [Abstract][Full Text] [Related]
9. Facilitative production of an antimicrobial peptide royalisin and its antibody via an artificial oil-body system.
Tseng JM; Huang JR; Huang HC; Tzen JT; Chou WM; Peng CC
Biotechnol Prog; 2011; 27(1):153-61. PubMed ID: 21312363
[TBL] [Abstract][Full Text] [Related]
10. Minimizing the central hydrophobic domain in oleosin for the constitution of artificial oil bodies.
Peng CC; Lee VS; Lin MY; Huang HY; Tzen JT
J Agric Food Chem; 2007 Jul; 55(14):5604-10. PubMed ID: 17567149
[TBL] [Abstract][Full Text] [Related]
11. Affibody-displaying bionanocapsules for specific drug delivery to HER2-expressing cancer cells.
Shishido T; Mieda H; Hwang SY; Nishimura Y; Tanaka T; Ogino C; Fukuda H; Kondo A
Bioorg Med Chem Lett; 2010 Oct; 20(19):5726-31. PubMed ID: 20801029
[TBL] [Abstract][Full Text] [Related]
12. [Changes in immune function of dendritic cells infected by recombinant adenovirus containing Her2/neu gene of extracellular and transmembrane domain proteins].
Ma SD; Luo RC; Ding ZH; Lu F; Yuan CQ
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1184-7. PubMed ID: 16939917
[TBL] [Abstract][Full Text] [Related]
13. Anti-HER2/neu IgG3-(IL-2) and anti-HER2/neu IgG3-(GM-CSF) promote HER2/neu processing and presentation by dendritic cells: implications in immunotherapy and vaccination strategies.
Dela Cruz JS; Trinh KR; Chen HW; Ribas A; Morrison SL; Penichet ML
Mol Immunol; 2006 Feb; 43(6):667-76. PubMed ID: 15908002
[TBL] [Abstract][Full Text] [Related]
14. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.
Kirpotin D; Park JW; Hong K; Zalipsky S; Li WL; Carter P; Benz CC; Papahadjopoulos D
Biochemistry; 1997 Jan; 36(1):66-75. PubMed ID: 8993319
[TBL] [Abstract][Full Text] [Related]
15. Site-specifically conjugated anti-HER2 Affibody molecules as one-step reagents for target expression analyses on cells and xenograft samples.
Lundberg E; Höidén-Guthenberg I; Larsson B; Uhlén M; Gräslund T
J Immunol Methods; 2007 Jan; 319(1-2):53-63. PubMed ID: 17196217
[TBL] [Abstract][Full Text] [Related]
16. Selective cytotoxicity to HER2-positive tumor cells by a recombinant e23sFv-TD-tBID protein containing a furin cleavage sequence.
Wang F; Ren J; Qiu XC; Wang LF; Zhu Q; Zhang YQ; Huan Y; Meng YL; Yao LB; Chen SY; Xu YM; Yang AG
Clin Cancer Res; 2010 Apr; 16(8):2284-94. PubMed ID: 20371697
[TBL] [Abstract][Full Text] [Related]
17. Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice.
Wei H; Wang S; Zhang D; Hou S; Qian W; Li B; Guo H; Kou G; He J; Wang H; Guo Y
Clin Cancer Res; 2009 Jul; 15(14):4612-21. PubMed ID: 19584156
[TBL] [Abstract][Full Text] [Related]
18. Affinity-based entrapment of the HER2 receptor in the endoplasmic reticulum using an affibody molecule.
Vernet E; Konrad A; Lundberg E; Nygren PA; Gräslund T
J Immunol Methods; 2008 Sep; 338(1-2):1-6. PubMed ID: 18671978
[TBL] [Abstract][Full Text] [Related]
19. Cell type dependent endocytic internalization of ErbB2 with an artificial peptide ligand that binds to ErbB2.
Hashizume T; Fukuda T; Nagaoka T; Tada H; Yamada H; Watanabe K; Salomon DS; Seno M
Cell Biol Int; 2008 Jul; 32(7):814-26. PubMed ID: 18442934
[TBL] [Abstract][Full Text] [Related]
20. Analysing c-kit internalization using a functional c-kit-EGFP chimera containing the fluorochrome within the extracellular domain.
Jahn T; Seipel P; Coutinho S; Urschel S; Schwarz K; Miething C; Serve H; Peschel C; Duyster J
Oncogene; 2002 Jul; 21(29):4508-20. PubMed ID: 12085229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
